Market Access Row over CF drug funding as NHS rejects Vertex offer Vertex 'astonished and dismayed' by NHS rejection
Views & Analysis Need for leaders as Value & Access plays increasing role in ... Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, on the evolution of the Value & Access function.
Views & Analysis Medical technology and digital: primary levers for change What steps can traditional pharma and medtech companies take to update their processes to support a move to more agile, digital business models?
Debates & Insight Sponsored Pricing and Market Access Outlook 2018 This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models that reward value and outcomes.
News A NICE yes for latest immunotherapy Bavencio NICE has recommended Merck KGaA and Pfizer’s Bavencio in previously treated metastatic Merkel Cell Carcinoma, a rare and aggressive form of skin cancer.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
